BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25880660)

  • 21. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
    Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
    JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysis.
    Flynn RW; MacDonald TM; Hapca A; MacKenzie IS; Schembri S
    Respir Res; 2014 Nov; 15(1):141. PubMed ID: 25407604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD.
    Short PM; Williamson PA; Elder DHJ; Lipworth SIW; Schembri S; Lipworth BJ
    Chest; 2012 Jan; 141(1):81-86. PubMed ID: 21799028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.
    Trudo F; Kern DM; Davis JR; Tunceli O; Zhou S; Graham EL; Strange C; Williams SA
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2055-66. PubMed ID: 26451101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescribed therapy for asthma: therapeutic ratios and outcomes.
    Laforest L; Licaj I; Devouassoux G; Eriksson I; Caillet P; Chatte G; Belhassen M; Van Ganse E
    BMC Fam Pract; 2015 Apr; 16():49. PubMed ID: 25880641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twenty-five statements on early initiation of fixed combination ICS/LABA treatment for asthma and COPD in primary and secondary care: consensus research by a modified Delphi process.
    Kardos P; Bechtel B; Palovis L; Hagedorn C; Latif F
    Pneumologie; 2012 Sep; 66(9):549-57. PubMed ID: 22899206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
    Kiri VA; Fabbri LM; Davis KJ; Soriano JB
    Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exacerbations, health services utilization, and costs in commercially-insured COPD patients treated with nebulized long-acting β2-agonists.
    Chen YJ; Makin C; Bollu VK; Navaie M; Celli BR
    J Med Econ; 2016; 19(1):11-20. PubMed ID: 26357881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
    Akazawa M; Biddle AK; Stearns SC
    Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
    Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
    [TBL] [Abstract][Full Text] [Related]  

  • 36.  Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study.
    Janson C; Johansson G; Ställberg B; Lisspers K; Olsson P; Keininger DL; Uhde M; Gutzwiller FS; Jörgensen L; Larsson K
    Respir Res; 2018 Sep; 19(1):172. PubMed ID: 30200965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time trends of period prevalence rates of patients with inhaled long-acting beta-2-agonists-containing prescriptions: a European comparative database study.
    Rottenkolber M; Voogd E; van Dijk L; Primatesta P; Becker C; Schlienger R; de Groot MC; Alvarez Y; Durand J; Slattery J; Afonso A; Requena G; Gil M; Alvarez A; Hesse U; Gerlach R; Hasford J; Fischer R; Klungel OH; Schmiedl S
    PLoS One; 2015; 10(2):e0117628. PubMed ID: 25706152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes.
    Price D; Jones R; Pfister P; Cao H; Carter V; Kemppinen A; Holzhauer B; Kaplan A; Clark A; Halpin DMG; Pinnock H; Chalmers JD; van Boven JFM; Beeh KM; Kostikas K; Roche N; Usmani O; Mastoridis P
    Pragmat Obs Res; 2021; 12():25-35. PubMed ID: 34079422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-World Data and Randomised Controlled Trials: The Salford Lung Study.
    Leather DA; Jones R; Woodcock A; Vestbo J; Jacques L; Thomas M
    Adv Ther; 2020 Mar; 37(3):977-997. PubMed ID: 31927698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying individuals with physician-diagnosed chronic obstructive pulmonary disease in primary care electronic medical records: a retrospective chart abstraction study.
    Lee TM; Tu K; Wing LL; Gershon AS
    NPJ Prim Care Respir Med; 2017 May; 27(1):34. PubMed ID: 28507288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.